Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 05-Aug-24 6:01 PM View:  | Gallman Cari EVP, Corporate Affairs | Bristol-Myers Squibb Co. (BMY) | 01-Aug-24 | Payment of Exercise | 384 | $48.17 | $18,497.30 | (15%) 2.49K to 2.11K | |
| 05-Aug-24 6:01 PM View: | Gallman Cari EVP, Corporate Affairs | Bristol-Myers Squibb Co. (BMY) | 01-Aug-24 | Option Exercise | 1,061 | -- | -- | 74% 1.43K to 2.49K | |
| 02-Apr-24 6:45 PM View: | Shanahan Karin EVP, Glob. Prod. Dev. & Supply | Bristol-Myers Squibb Co. (BMY) | 01-Apr-24 | Payment of Exercise | 1,196 | $52.99 | $63,376.00 | (16%) 7.35K to 6.16K | |
| 02-Apr-24 6:45 PM View: | Shanahan Karin EVP, Glob. Prod. Dev. & Supply | Bristol-Myers Squibb Co. (BMY) | 01-Apr-24 | Option Exercise | 3,306 | -- | -- | 82% 4.04K to 7.35K | |
| 12-Mar-24 7:58 PM View: | Boerner Christopher S. Chief Executive Officer Director | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 16,698 | -- | -- | (14%) 117.9K to 101.2K | |
| 12-Mar-24 9:54 PM View: | Lenkowsky Adam EVP, Chief Commercial Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 15,016 | -- | -- | 149% 10.08K to 25.09K | |
| 12-Mar-24 8:40 PM View: | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 38,388 | -- | -- | 81% 47.24K to 85.63K | |
| 12-Mar-24 9:21 PM View: | Plenge Robert M EVP, Chief Research Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 1,965 | $53.79 | $105,697.00 | (11%) 17.93K to 15.96K | |
| 12-Mar-24 9:21 PM View: | Plenge Robert M EVP, Chief Research Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 9,143 | -- | -- | 104% 8.78K to 17.93K | |
| 12-Mar-24 8:00 PM View: | Gallman Cari EVP, Corporate Affairs | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 2,761 | -- | -- | 1340% 0.21K to 2.97K | |
| 12-Mar-24 8:01 PM View: | Hoch Lynelle President, Cell Therapy Org. | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 4,351 | -- | -- | 100% 0 to 4.35K | |
| 12-Mar-24 9:11 PM View: | Poole Ahn Amanda EVP, Chief Human Resources | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 5,458 | -- | -- | 3328% 0.16K to 5.62K | |
| 12-Mar-24 8:31 PM View: | Holzer Phil M SVP and Controller | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 5,520 | -- | -- | 55% 10.01K to 15.53K | |
| 12-Mar-24 5:42 PM View: | Caforio Giovanni Executive Chair of the Board Director | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 190,130 | -- | -- | 52% 367.5K to 557.63K | |
| 12-Mar-24 5:43 PM View: | Elkins David V EVP, Chief Financial Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 18,522 | $53.79 | $996,298.00 | (8%) 233.15K to 214.63K | |
| 12-Mar-24 9:54 PM View: | Lenkowsky Adam EVP, Chief Commercial Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 4,323 | $53.79 | $232,534.00 | (17%) 25.09K to 20.77K | |
| 12-Mar-24 7:58 PM View: | Boerner Christopher S. Chief Executive Officer Director | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 54,638 | -- | -- | 66% 82.67K to 137.31K | |
| 12-Mar-24 9:43 PM View: | Leung Sandra EVP, General Counsel | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 16,660 | $53.79 | $896,141.00 | (3%) 478.92K to 462.26K | |
| 12-Mar-24 5:43 PM View: | Elkins David V EVP, Chief Financial Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 64,326 | -- | -- | 38% 168.83K to 233.15K | |
| 12-Mar-24 9:43 PM View: | Leung Sandra EVP, General Counsel | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 14,153 | -- | -- | (3%) 462.26K to 448.11K | |
| 12-Mar-24 8:40 PM View: | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 13,649 | $53.79 | $734,180.00 | (16%) 85.63K to 71.98K | |
| 12-Mar-24 9:21 PM View: | Plenge Robert M EVP, Chief Research Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 2,789 | -- | -- | (17%) 15.96K to 13.17K | |
| 12-Mar-24 8:00 PM View: | Gallman Cari EVP, Corporate Affairs | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 696 | $53.79 | $37,437.80 | (23%) 2.97K to 2.27K | |
| 12-Mar-24 8:01 PM View: | Hoch Lynelle President, Cell Therapy Org. | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 1,308 | $53.79 | $70,357.30 | (30%) 4.35K to 3.04K | |
| 12-Mar-24 9:11 PM View: | Poole Ahn Amanda EVP, Chief Human Resources | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 1,375 | $53.79 | $73,961.20 | (24%) 5.62K to 4.25K | |
| 12-Mar-24 8:31 PM View: | Holzer Phil M SVP and Controller | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 1,389 | $53.79 | $74,714.30 | (9%) 15.53K to 14.14K | |
| 12-Mar-24 5:42 PM View: | Caforio Giovanni Executive Chair of the Board Director | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 67,823 | $53.79 | $3,648,200.00 | (12%) 557.63K to 489.8K | |
| 12-Mar-24 7:58 PM View: | Boerner Christopher S. Chief Executive Officer Director | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Payment of Exercise | 19,407 | $53.79 | $1,043,900.00 | (14%) 137.31K to 117.9K | |
| 12-Mar-24 5:43 PM View: | Elkins David V EVP, Chief Financial Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 19,448 | -- | -- | (9%) 214.63K to 195.18K | |
| 12-Mar-24 9:54 PM View: | Lenkowsky Adam EVP, Chief Commercial Officer | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 4,569 | -- | -- | (22%) 20.77K to 16.2K | |
| 12-Mar-24 9:43 PM View: | Leung Sandra EVP, General Counsel | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Option Exercise | 46,784 | -- | -- | 11% 432.13K to 478.92K | |
| 12-Mar-24 8:40 PM View: | Hirawat Samit EVP,Chief Med.Offr.,Drug Dev. | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 11,705 | -- | -- | (16%) 71.98K to 60.28K | |
| 12-Mar-24 8:00 PM View: | Gallman Cari EVP, Corporate Affairs | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 839 | -- | -- | (37%) 2.27K to 1.43K | |
| 12-Mar-24 8:01 PM View: | Hoch Lynelle President, Cell Therapy Org. | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 1,317 | -- | -- | (43%) 3.04K to 1.73K | |
| 12-Mar-24 9:11 PM View: | Poole Ahn Amanda EVP, Chief Human Resources | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 1,659 | -- | -- | (39%) 4.25K to 2.59K | |
| 12-Mar-24 8:31 PM View: | Holzer Phil M SVP and Controller | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 1,682 | -- | -- | (12%) 14.14K to 12.46K | |
| 12-Mar-24 5:42 PM View: | Caforio Giovanni Executive Chair of the Board Director | Bristol-Myers Squibb Co. (BMY) | 10-Mar-24 | Disposition (other) | 57,536 | -- | -- | (12%) 489.8K to 432.27K | |
| 05-Feb-24 7:10 PM View: | Meyers Gregory Scott EVP, Chief Digital & Tech Off. | Bristol-Myers Squibb Co. (BMY) | 01-Feb-24 | Option Exercise | 2,543 | -- | -- | 73% 3.5K to 6.04K | |
| 05-Feb-24 7:10 PM View: | Meyers Gregory Scott EVP, Chief Digital & Tech Off. | Bristol-Myers Squibb Co. (BMY) | 01-Feb-24 | Payment of Exercise | 754 | $48.67 | $36,697.20 | (12%) 6.04K to 5.29K | |
| 07-Dec-23 6:06 PM View: | Boerner Christopher S. Chief Executive Officer | Bristol-Myers Squibb Co. (BMY) | 05-Dec-23 | Private Purchase | 2,000 | $49.78 | $99,560.00 | 2% 80.67K to 82.67K | |
| 05-Dec-23 6:22 PM View: | Elkins David V EVP, Chief Financial Officer | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Option Exercise | 8,792 | -- | -- | 5% 163.76K to 172.56K | |
| 05-Dec-23 6:21 PM View: | Boerner Christopher S. Chief Executive Officer | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Payment of Exercise | 1,350 | $50.10 | $67,635.00 | (2%) 82.02K to 80.67K | |
| 05-Dec-23 6:21 PM View: | Boerner Christopher S. Chief Executive Officer | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Option Exercise | 2,638 | -- | -- | 3% 79.38K to 82.02K | |
| 05-Dec-23 6:23 PM View: | Plenge Robert M EVP, Chief Research Officer | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Payment of Exercise | 274 | $50.10 | $13,727.40 | (4%) 7.4K to 7.13K | |
| 05-Dec-23 6:23 PM View: | Plenge Robert M EVP, Chief Research Officer | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Option Exercise | 616 | -- | -- | 9% 6.78K to 7.4K | |
| 05-Dec-23 6:22 PM View: | Elkins David V EVP, Chief Financial Officer | Bristol-Myers Squibb Co. (BMY) | 02-Dec-23 | Payment of Exercise | 3,730 | $50.10 | $186,873.00 | (2%) 172.56K to 168.82K | |
| 30-Nov-23 6:32 PM View: | Boerner Christopher S. Chief Executive Officer | Bristol-Myers Squibb Co. (BMY) | 28-Nov-23 | Private Purchase | 3,071 | $48.86 | $150,049.00 | 4% 76.31K to 79.38K | |
| 24-Nov-23 2:38 PM View: | Leung Sandra EVP, General Counsel | Bristol-Myers Squibb Co. (BMY) | 21-Nov-23 | Disposition (other) | 9,830 | $48.74 | $479,163.00 | (2%) 441.88K to 432.05K | |
| 24-Nov-23 2:38 PM View: | Leung Sandra EVP, General Counsel | Bristol-Myers Squibb Co. (BMY) | 21-Nov-23 | Acquisition (other) | 9,830 | $48.74 | $479,163.00 | 2% 432.05K to 441.88K | |
| 21-Nov-23 7:01 PM View: | Samuels Theodore R. II Director | Bristol-Myers Squibb Co. (BMY) | 20-Nov-23 | Private Purchase | 8,500 | $49.81 | $423,385.00 | 31% 27.0K to 35.5K |
